Credentialing

Hartford HealthCare Taps Axuall to Tackle Workforce Shortages and Clinician Burnout

Retrieved on: 
Tuesday, April 2, 2024
Automation, Intelligence, Partnership, Patient, Credentialing, MSN, Safety, Workforce, Health, Pharmaceutical industry

CLEVELAND, April 02, 2024 (GLOBE NEWSWIRE) -- Axuall , the leader in healthcare workforce intelligence and Hartford HealthCare , Connecticut's most comprehensive healthcare network, announced today that Axuall was selected to support Hartford HealthCare’s plan to bolster its workforce and reduce caregiver burnout.

Key Points: 
  • CLEVELAND, April 02, 2024 (GLOBE NEWSWIRE) -- Axuall , the leader in healthcare workforce intelligence and Hartford HealthCare , Connecticut's most comprehensive healthcare network, announced today that Axuall was selected to support Hartford HealthCare’s plan to bolster its workforce and reduce caregiver burnout.
  • Axuall’s solution enables newly hired clinicians to be onboarded up to 15 days faster, allowing them to see patients sooner, and eliminate burdens for current Hartford HealthCare clinicians.
  • Hartford Healthcare will now be able to study clinician populations inside and outside its network, identify gaps and surpluses, and match and recruit talent.
  • “Hartford HealthCare's strategic embrace of workforce intelligence technology reflects a commitment to staying ahead in the ever-evolving landscape of healthcare,” shared Charlie Lougheed, Chief Executive Officer and co-founder of Axuall.

CertifyOS Unveils New Design and Brand Identity

Retrieved on: 
Tuesday, April 9, 2024
Element, API, Oscar Health, Credentialing, Mobile phone

NEW YORK, April 9, 2024 /PRNewswire/ -- CertifyOS, a first-of-its-kind provider data intelligence platform, powered by API integrations and thousands of verified data points, today announced the launch of its brand refresh and new website design. The elevated visual identity reinforces CertifyOS' reputation as a reliable partner in cutting-edge data infrastructure management and emphasizes the company's commitment to innovation and excellence in improving healthcare access.

Key Points: 
  • NEW YORK, April 9, 2024 /PRNewswire/ -- CertifyOS , a first-of-its-kind provider data intelligence platform, powered by API integrations and thousands of verified data points, today announced the launch of its brand refresh and new website design.
  • "Our steadfast mission to build the data infrastructure that powers the next generation of provider data products driving streamlined data processes, empowering businesses, and illuminating pathways to effortless decision-making is represented in our new brand identity through both vibrant design elements and strategic messaging," said Anshul Rathi , Founder and CEO of CertifyOS.
  • "The rollout of our new brand identity is a pivotal moment in CertifyOS' journey, as this visually represents our company's unwavering commitment to becoming a pioneer for frictionless provider data intelligence."
  • CertifyOS' focus on warmth and human-centric design ensures that it stands out as a company that prioritizes user experience and customer satisfaction.

Precision Oncology Innovator SimBioSys and General Inception Announce Strategic Partnership to Accelerate Cancer Drug Development

Retrieved on: 
Wednesday, April 3, 2024
Oncology, Health, Other Health, Research, Science, Pharmaceutical, Biotechnology, Pyrotechnic initiator, Partnership, Patient, Neoplasm, Biomarker, GI, Credentialing, Cancer, AI, Clinical trial, Drug development, Therapy, Pharmaceutical industry

SimBioSys, a leading innovator in precision oncology, and General Inception (“GI”), a global company Igniter, today announced a strategic partnership that aims to significantly reduce oncology drug development times and cut development costs by using AI and biophysical modeling to better understand unique tumor spatial biophysical characteristics.

Key Points: 
  • SimBioSys, a leading innovator in precision oncology, and General Inception (“GI”), a global company Igniter, today announced a strategic partnership that aims to significantly reduce oncology drug development times and cut development costs by using AI and biophysical modeling to better understand unique tumor spatial biophysical characteristics.
  • The level of drug development in oncology is intense, with more than 2,000 products currently under development and drug trial starts up 22% in 2022 compared to 2018.
  • By partnering with General Inception, we can cut their oncology drug development time and costs significantly.
  • This strategic relationship not only underscores our commitment to innovation in the fight against cancer but also promises to deliver groundbreaking precision oncology drugs to patients faster than ever before.”

BerryDunn Continues Significant Growth Among the Accounting Today 2024 Top 100 Firms

Retrieved on: 
Wednesday, April 3, 2024
Consulting, Banking, Professional Services, Finance, Renewable energy, Accounting, Consultant, Credentialing, Local government

BerryDunn, a full-service assurance, tax, and consulting firm, grew by 21% in 2023, earning the top position among 15 New England accounting firms.

Key Points: 
  • BerryDunn, a full-service assurance, tax, and consulting firm, grew by 21% in 2023, earning the top position among 15 New England accounting firms.
  • The firm ranks 43 overall in Accounting Today’s 2024 Top 100 Firms in the US , based on net revenue.
  • For the third consecutive year, BerryDunn is listed in the Top 50, up from ranking 46 last year.
  • “Our success is attributed to our dedicated employees who proactively develop new services and solutions to help clients thrive,” explains Chad Snow, COO of Consulting Services.

CHG Healthcare Announces Advisory Services

Retrieved on: 
Wednesday, March 27, 2024
Nursing, Hospitals, Consulting, Health Technology, Professional Services, Practice Management, Other Health, Managed Care, Health, Organization, CHG, Telehealth, Travel, Hospital, History, Credentialing, MBA, Workforce, Map, CPA

CHG Healthcare has announced the launch of a new advisory services branch.

Key Points: 
  • CHG Healthcare has announced the launch of a new advisory services branch.
  • Advisory Services from CHG Healthcare, as it will be known, will provide consulting services to help hospitals and healthcare organizations deal with mounting provider shortages, rising costs, shrinking revenues, lack of visibility and slow adoption of technology.
  • 1 issue facing healthcare organizations, and advisory support on this issue has, up to this point, been fragmented or incomplete to support them in solving this issue,” said Austin Chatlin, Director of Advisory Services.
  • “I could not be more excited to join CHG Healthcare and be part of the Advisory Services team,” said Polenz.

Precision Oncology Innovator SimBioSys and General Inception Announce Strategic Partnership to Accelerate Cancer Drug Development

Retrieved on: 
Wednesday, April 3, 2024
Pyrotechnic initiator, Partnership, Patient, Neoplasm, Biomarker, Credentialing, Cancer, AI, Drug development, PALO, Clinical trial, Therapy, Simbiosys, Pharmaceutical industry

CHICAGO & PALO ALTO, Calif., April 3, 2024 /PRNewswire/ -- SimBioSys, a leading innovator in precision oncology, and General Inception ("GI"), a global company Igniter, today announce a strategic partnership that aims to significantly reduce oncology drug development times and cut development costs by using AI and biophysical modeling to better understand unique tumor spatial biophysical characteristics.

Key Points: 
  • Drug development in oncology is at high levels, with more than 2,000 products currently under development and drug trial starts up 22% in 2022 from 2018.
  • [1]
    Venkat Reddy, Chief Scientific Officer of General Inception, said: "This collaboration marks a significant milestone in the pursuit of more effective, personalized cancer therapies, as all new oncology drug incubations under General Inception will be able to use SimBioSys' state-of-the-art PhenoScope platform and drug development services.
  • Tushar Pandey, Chief Executive Officer of SimBioSys, said: "Together, we are committed to introducing much-needed precision to the drug development process.
  • By partnering with General Inception, we can cut their oncology drug development time and costs significantly.

Precision Oncology Innovator SimBioSys and General Inception Announce Strategic Partnership to Accelerate Cancer Drug Development

Retrieved on: 
Wednesday, April 3, 2024
Pyrotechnic initiator, Partnership, Patient, Neoplasm, Biomarker, Credentialing, Cancer, AI, Drug development, PALO, Clinical trial, Therapy, Simbiosys, Pharmaceutical industry

CHICAGO & PALO ALTO, Calif., April 3, 2024 /PRNewswire/ -- SimBioSys, a leading innovator in precision oncology, and General Inception ("GI"), a global company Igniter, today announce a strategic partnership that aims to significantly reduce oncology drug development times and cut development costs by using AI and biophysical modeling to better understand unique tumor spatial biophysical characteristics.

Key Points: 
  • Drug development in oncology is at high levels, with more than 2,000 products currently under development and drug trial starts up 22% in 2022 from 2018.
  • [1]
    Venkat Reddy, Chief Scientific Officer of General Inception, said: "This collaboration marks a significant milestone in the pursuit of more effective, personalized cancer therapies, as all new oncology drug incubations under General Inception will be able to use SimBioSys' state-of-the-art PhenoScope platform and drug development services.
  • Tushar Pandey, Chief Executive Officer of SimBioSys, said: "Together, we are committed to introducing much-needed precision to the drug development process.
  • By partnering with General Inception, we can cut their oncology drug development time and costs significantly.

Chartis reestablishes the Greeley brand; Appoints Tim Barger President

Retrieved on: 
Thursday, March 28, 2024
Organization, Patient, Credentialing, Barger, CME, Workforce, Interim, Consultant, MSSD, Nursing

CHICAGO, March 28, 2024 /PRNewswire/ -- Chartis, a comprehensive healthcare advisory firm, today announced that its line of business focused on helping medical staff services departments (MSSDs) transform to elevate performance will restore its former name—Greeley, A Chartis Company. It also announced Tim Barger has been named President of the organization and will lead its strategic growth and enterprise operations. 

Key Points: 
  • It also announced Tim Barger has been named President of the organization and will lead its strategic growth and enterprise operations.
  • With more than 200 full-time and independent healthcare leaders, medical services professionals, and consultants, Greeley is an industry leader in developing solutions to help propel the evolution of medical staff services.
  • "Tim and Sally have demonstrated exceptional leadership and vision supporting our clients in addressing their most critical MSSD and workforce needs.
  • Prior to joining Greeley, Barger was the Founder and President of Talentum, a human capital management consulting firm.

Simplilearn Bags Two Awards at the EC-Council Global Award for the Sixth Time

Retrieved on: 
Wednesday, March 27, 2024
Online, Certification, Organization, CEH, ATC, SAN, Education, Knowledge, Credentialing, Enterprise, Faculty, Student, Certified Ethical Hacker, EC-Council, Workforce, Best Newcomer, Nursing

In recognition of its excellence, Simplilearn has been honored with both the 'EC-Council ATC of the Year Award' and the 'EC-Council Circle of Excellence Award (Enterprise)' for the year 2023.

Key Points: 
  • In recognition of its excellence, Simplilearn has been honored with both the 'EC-Council ATC of the Year Award' and the 'EC-Council Circle of Excellence Award (Enterprise)' for the year 2023.
  • The '2023 EC-Council ATC of the Year Award' is a testament to Simplilearn's commitment to cybersecurity education, substantially impacting the global cybersecurity workforce.
  • Kashyap Dalal, Co-founder and COO, of Simplilearn, said, "We are honored to be recognized by EC-Council for the sixth time.
  • Additionally, Simplilearn has earned Training Industry Magazine's Top 20 Online Learning Library awards in 2020, 2019, and 2018, along with the 2020 Top 20 IT Training Company Award.

Simplilearn Bags Two Awards at the EC-Council Global Award for the Sixth Time

Retrieved on: 
Wednesday, March 27, 2024
Online, Certification, Organization, CEH, ATC, SAN, Education, Knowledge, Credentialing, Enterprise, Faculty, Student, Certified Ethical Hacker, EC-Council, Workforce, Best Newcomer, Nursing

In recognition of its excellence, Simplilearn has been honored with both the 'EC-Council ATC of the Year Award' and the 'EC-Council Circle of Excellence Award (Enterprise)' for the year 2023.

Key Points: 
  • In recognition of its excellence, Simplilearn has been honored with both the 'EC-Council ATC of the Year Award' and the 'EC-Council Circle of Excellence Award (Enterprise)' for the year 2023.
  • The '2023 EC-Council ATC of the Year Award' is a testament to Simplilearn's commitment to cybersecurity education, substantially impacting the global cybersecurity workforce.
  • Kashyap Dalal, Co-founder and COO, of Simplilearn, said, "We are honored to be recognized by EC-Council for the sixth time.
  • Additionally, Simplilearn has earned Training Industry Magazine's Top 20 Online Learning Library awards in 2020, 2019, and 2018, along with the 2020 Top 20 IT Training Company Award.